REDCARE PHARMACY NV HAUPTVERSAMMLUNG 2022.
DGAP-News: SHOP APOTHEKE EUROPE N.V. / Schlagwort(e): Hauptversammlung
SHOP APOTHEKE EUROPE N.V. VERÖFFENTLICHT AGENDA DER ORDENTLICHEN
HAUPTVERSAMMLUNG 2022.
03.03.2022 / 11:50
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.
------------------------------------------------------------
HINWEIS: DIESE MITTEILUNG IST NUR IN ENGLISCHER SPRACHE VERFÜGBAR. NOT FOR
DIRECT OR INDIRECT RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED
STATES OF AMERICA, CANADA, SOUTH AFRICA, AUSTRALIA OR JAPAN.
SHOP APOTHEKE EUROPE N.V. PUBLISHES AGENDA ANNUAL GENERAL MEETING OF
SHAREHOLDERS 2022
Sevenum, 3 March 2022. SHOP APOTHEKE EUROPE N.V. ("SHOP APOTHEKE EUROPE" or the
"Company") has today published the agenda for the annual general meeting of
shareholders of the Company (the "AGM") to be held virtually on 14 April 2022.
The convocation announcement and the agenda, the accompanying explanatory notes
and other information/documentation are available on the corporate website of
the Company (http://shop-apotheke-europe.com) under Investor Relations /
General Meeting / Annual General Meeting 2022 and via the link
http://shop-apotheke-europe.com/en/investorrelations/hauptversammlung/
The AGM will take place on 14 April 2022 starting at 10:00 CEST, and will take
place fully virtually this year on the basis of the Dutch Temporary Law
Covid-19 Justice and Safety (the "Emergency Law"). The Company believes that a
virtual meeting is the most prudent decision in view of the ongoing Covid-19
pandemic and considering the current guidelines of the Dutch government
regarding the Covid-19 pandemic. This means that no visitors or shareholders
can attend the meeting in person. The Company's shareholders, who are entitled
to participate and exercise voting rights, can take part in the annual general
meeting via the webcast on 14 April 2022 and can vote virtually during the
meeting, in each case via an online platform provided by the Company's service
provider for annual general meetings (such online platform, the "Virtual AGM
Platform"). Furthermore, shareholders can ask questions either during the
meeting and/or prior to the date of the meeting. The terms and conditions
regarding virtual general meetings are available on the virtual AGM platform
and apply to all shareholders who wish to attend, participate and vote at the
meeting via the Virtual AGM Platform. Please refer to Section 3 (General
Information) of the convocation announcements for further details regarding how
to submit questions, attend, participate and vote at the AGM via the Virtual
AGM Platform.
Should the Emergency Law no longer apply on 14 April 2022, the Company will not
be able to hold the annual general meeting fully virtually and, therefore, the
annual general meeting will then take place on the same date and at the same
time both virtually via the virtual AGM Platform and with limited access in
person at Erik de Rodeweg 11-13, 5975 WD Sevenum (such meeting, the "Hybrid
Meeting"). In the event that the annual general meeting must be held in the
form of the Hybrid Meeting, the Company urges all its shareholders to carefully
consider whether they wish to attend the annual general meeting in person at
the venue in Sevenum in view of possible health risks relating to the ongoing
Covid-19 pandemic. The Company gives top priority to the health of its
employees, shareholders and other stakeholders and, therefore, the Company
strongly encourages its shareholders to take part in the annual general meeting
via the webcast on 14 April 2022 and vote virtually during the meeting, in each
case via the Virtual AGM Platform, and not to attend the Hybrid Meeting in
person. This way, the Hybrid Meeting can take place with only a limited number
of core attendees and health risks for those attendees can be limited as much
as possible. If the annual general meeting this year will need to be held in
the form of the Hybrid Meeting, the Company will announce that on the Company's
corporate website before 14 April 2022.
For further information please contact us at:
General AGM related matters:
Rens Jan Kramer
Telephone: +31 6 46 18 67 23
Email: rensjan.kramer@shop-apotheke.com
Trade and public media:
Sven Schirmer
Mobile: +49 152 28 50 63 61
Email: presse@shop-apotheke.com
Financial media:
Thomas Schnorrenberg
Mobile: +49 151 46 53 13 17
Email: presse@shop-apotheke.com
------------------------------------------------------------
03.03.2022 Veröffentlichung einer Corporate News/Finanznachricht, übermittelt
durch DGAP - ein Service der EQS Group AG.
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.
Die DGAP Distributionsservices umfassen gesetzliche Meldepflichten, Corporate
News/Finanznachrichten und Pressemitteilungen.
Medienarchiv unter http://www.dgap.de
------------------------------------------------------------
Sprache: Deutsch
Unternehmen: SHOP APOTHEKE EUROPE N.V.
Erik de Rodeweg 11-13
5975 WD Sevenum
Niederlande
Telefon: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-Mail: carmen.herkenrath@shop-apotheke.com
Internet: www.shop-apotheke-europe.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y07
Indizes: SDAX
Börsen: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in
Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart,
Tradegate Exchange
EQS News ID: 1293879
Ende der Mitteilung DGAP News-Service
------------------------------------------------------------
1293879 03.03.2022
